Skip to content

Clinical trial for Halcyon in the treatment of tumor

medical Linac clinical trial

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-17012766
Enrollment
Unknown
Registered
2017-09-21
Start date
2017-09-28
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tumors

Interventions

single arm:RT

Sponsors

Varian Medical Systems
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) signed IC, aged 18 - 70 years; 2) Cancer; 3) provide IC.

Exclusion criteria

Exclusion criteria: 1) RT before 2) Investigator assess to exclude.

Design outcomes

Primary

MeasureTime frame
Radial treatment;

Countries

China

Contacts

Public ContactZhao Jian

Varian Medical Systems Trading (Beijing) Co., Ltd

jian.zhao@varian.com+86 18811615537

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026